Ishii N - Search Results

1

Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo.

Yanagi K, Nagayama Y, Nakao K, Saeki A, Matsumoto K, Ichikawa T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K. Yanagi K, et al. Among authors: ishii n. Int J Oncol. 2003 Feb;22(2):345-51. Int J Oncol. 2003. PMID: 12527933

2

Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.

Arima T, Nakao K, Nakata K, Ishikawa H, Ichikawa T, Hamasaki K, Ishii N, Eguchi K. Arima T, et al. Among authors: ishii n. Int J Mol Med. 2002 Apr;9(4):397-400. Int J Mol Med. 2002. PMID: 11891535

3

Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.

Saeki A, Nakao K, Nagayama Y, Yanagi K, Matsumoto K, Hayashi T, Ishikawa H, Hamasaki K, Ishii N, Eguchi K. Saeki A, et al. Among authors: ishii n. Int J Mol Med. 2004 Jan;13(1):111-6. Int J Mol Med. 2004. PMID: 14654980

4

Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.

Hayashi T, Nakao K, Nagayama Y, Saitoh O, Ichikawa T, Ishikawa H, Hamasaki K, Eguchi K, Ishii N. Hayashi T, et al. Among authors: ishii n. Int J Oncol. 2005 May;26(5):1313-9. Int J Oncol. 2005. PMID: 15809723

5

Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide.

Motoyoshi Y, Kaminoda K, Saitoh O, Hamasaki K, Nakao K, Ishii N, Nagayama Y, Eguchi K. Motoyoshi Y, et al. Among authors: ishii n. Oncol Rep. 2006 Jul;16(1):141-6. Oncol Rep. 2006. PMID: 16786137

6

Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.

Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K, Ishii N. Nakao K, et al. Among authors: ishii n. Oncol Rep. 2006 Aug;16(2):389-92. Oncol Rep. 2006. PMID: 16820920

7

Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.

Ichikawa T, Nakao K, Nakata K, Yamashita M, Hamasaki K, Shigeno M, Abiru S, Ishikawa H, Ishii N, Eguchi K. Ichikawa T, et al. Among authors: ishii n. Biochem Biophys Res Commun. 2002 Jun 7;294(2):414-22. doi: 10.1016/S0006-291X(02)00502-8. Biochem Biophys Res Commun. 2002. PMID: 12051728

8

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells.

Tamada Y, Nakao K, Nagayama Y, Nakata K, Ichikawa T, Kawamata Y, Ishikawa H, Hamasaki K, Eguchi K, Ishii N. Tamada Y, et al. Among authors: ishii n. J Hepatol. 2002 Oct;37(4):493-9. doi: 10.1016/s0168-8278(02)00232-5. J Hepatol. 2002. PMID: 12217603

9

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.

Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K. Shigeno M, et al. Among authors: ishii n. Oncogene. 2003 Mar 20;22(11):1653-62. doi: 10.1038/sj.onc.1206139. Oncogene. 2003. PMID: 12642868

10

Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.

Tanaka K, Towata S, Nakao K, Mizuguchi H, Hayakawa T, Niwa M, Ishii N, Nagayama Y. Tanaka K, et al. Among authors: ishii n. Clin Endocrinol (Oxf). 2003 Dec;59(6):734-42. doi: 10.1046/j.1365-2265.2003.01915.x. Clin Endocrinol (Oxf). 2003. PMID: 14974915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,703 results

Search Page

Filters